Recent

% | $
Quotes you view appear here for quick access.

BioMarin Pharmaceutical Inc. Message Board

  • jockne40 jockne40 Sep 19, 2013 12:43 PM Flag

    Roche isn't denying its looking

    BioMarin off highs after Roche CEO downplays takeover report
    Drug maker BioMarin (BMRN) is climbing after a website reported that giant pharmaceutical company Roche (RHHBY) is planning to raise money in order to buy BioMarin. However, BioMarin's stock is well of its highs after Roche's CEO told Bloomberg that his company wasn't raising money for an acquisition. WHAT'S NEW: Roche is "on the verge" of raising up to $15 billion in debt that it would use to an acquire BioMarin, dealReporter stated earlier today, citing unnamed sources. The debt raise is being led by UBS (UBS), the website added. But in an interview today with Bloomberg, Roche CEO Severin Schwan denied that his company is raising funds for an acquisition. However, he refused to comment on what he called "rumors" of a potential acquisition of BioMarin by Roche. Schwan did say, though, he would pursue a "good strategic opportunity" if he saw one, Bloomberg noted. TODAY'S PRICE ACTION: In early afternoon trading, BioMarin rose $1.30, or 1.7%, to $78.80, but was well off its high for the day of $80.67. Roche inched up 0.2% to $65.90.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
BMRN
133.18+2.29(+1.75%)Aug 28 4:00 PMEDT